Prudential Financial Inc Biocryst Pharmaceuticals Inc Transaction History

Prudential Financial Inc

$80 Billion
Q3 2025

A detailed history of Prudential Financial Inc transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Prudential Financial Inc holds 394,565 shares of BCRX stock, worth $2.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

394,565

Previous 429,335 8.1%

Holding current value

$2.79 Million

Previous $3.85 Million 22.15%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$7.55 - $9.06 $262,513 - $315,016	-34,770 Reduced 8.1%	394,565 $2.99 Million
Q2 2025 Aug 12, 2025	SELL	$6.41 - $11.19 $1.03 Million - $1.79 Million	-159,975 Reduced 27.15%	429,335 $3.85 Million
Q1 2025 May 13, 2025	SELL	$7.06 - $9.39 $2.78 Million - $3.7 Million	-393,723 Reduced 40.05%	589,310 $4.42 Million
Q4 2024 Feb 11, 2025	BUY	$7.03 - $8.43 $636,939 - $763,783	90,603 Added 10.15%	983,033 $7.39 Million
Q3 2024 Nov 13, 2024	BUY	$6.41 - $8.69 $5.62 Million - $7.61 Million	876,205 Added 5400.34%	892,430 $6.78 Million
Q2 2024 Aug 13, 2024	BUY	$4.13 - $6.79 $7,268 - $11,950	1,760 Added 12.17%	16,225 $100,000
Q4 2023 Feb 13, 2024	BUY	$4.98 - $6.77 $2,290 - $3,114	460 Added 3.28%	14,465 $86,000
Q1 2023 May 12, 2023	SELL	$7.94 - $11.84 $436 - $651	-55 Reduced 0.39%	14,005 $116,000
Q4 2022 Feb 14, 2023	SELL	$10.5 - $14.2 $2,362 - $3,195	-225 Reduced 1.58%	14,060 $0
Q3 2022 Nov 04, 2022	BUY	$10.79 - $14.81 $2,481 - $3,406	230 Added 1.64%	14,285 $155,000
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $2,369 - $4,050	205 Added 1.48%	14,055 $228,000
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $13,975 - $19,325	-1,250 Reduced 8.28%	13,850 $192,000
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $17,478 - $21,709	1,230 Added 8.87%	15,100 $217,000
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $2,280 - $4,137	240 Added 1.76%	13,870 $219,000
Q1 2021 May 12, 2021	SELL	$7.37 - $13.61 $6,780 - $12,521	-920 Reduced 6.32%	13,630 $139,000
Q4 2020 Feb 16, 2021	BUY	$3.37 - $8.61 $6,301 - $16,100	1,870 Added 14.75%	14,550 $108,000
Q3 2020 Nov 16, 2020	BUY	$3.43 - $5.53 $3,052 - $4,921	890 Added 7.55%	12,680 $43,000
Q2 2020 Aug 12, 2020	BUY	$1.9 - $5.61 $1,121 - $3,309	590 Added 5.27%	11,790 $56,000
Q1 2020 May 12, 2020	BUY	$1.6 - $4.11 $288 - $739	180 Added 1.63%	11,200 $22,000
Q4 2019 Feb 11, 2020	BUY	$1.59 - $3.45 $651 - $1,414	410 Added 3.86%	11,020 $38,000
Q2 2019 Aug 08, 2019	BUY	$2.91 - $9.15 $407 - $1,281	140 Added 1.34%	10,610 $0
Q4 2018 Feb 07, 2019	SELL	$6.51 - $9.6 $1,497 - $2,208	-230 Reduced 2.15%	10,470 $84,000
Q3 2018 Nov 07, 2018	BUY	$5.52 - $7.99 $59,063 - $85,493	10,700 New	10,700 $0

Others Institutions Holding BCRX

# of Institutions

311

Shares Held

202M

Call Options Held

765K

Put Options Held

511K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.32B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Biocryst Pharmaceuticals Inc Transaction History